IMC Chicago’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Sell
142,200
-127,900
-47% -$431K ﹤0.01% 4070
2025
Q4
$764K Buy
270,100
+85,000
+46% +$438K ﹤0.01% 3179
2025
Q3
$1.29M Buy
185,100
+47,900
+35% +$338K ﹤0.01% 2540
2025
Q2
$812K Sell
137,200
-65,100
-32% -$374K ﹤0.01% 2600
2025
Q1
$1.29M Buy
202,300
+32,900
+19% +$317K ﹤0.01% 2105
2024
Q4
$2.01M Buy
169,400
+109,000
+180% +$1.86M ﹤0.01% 1873
2024
Q3
$1.67M Buy
60,400
+29,200
+94% +$731K ﹤0.01% 1777
2024
Q2
$744K Buy
31,200
+13,000
+71% +$305K ﹤0.01% 2120
2024
Q1
$320K Buy
+18,200
New +$268K ﹤0.01% 2221

Other funds holding ASPN

IMC Chicago's ASPN Position: Q1 2026 in Review

IMC Chicago reduced its Aspen Aerogels (ASPN) stake by 78% in Q1 2026, selling an estimated $271K and leaving 22,470 shares worth $76.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5412.

IMC Chicago first reported a position in ASPN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.45M in Q4 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • IMC Chicago held 22,470 shares of Aspen Aerogels worth $76.8K as of Q1 2026.
  • IMC Chicago sold 80,460 Aspen Aerogels shares in Q1 2026, an estimated $271K.
  • Aspen Aerogels made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5412 holding.
  • IMC Chicago first reported a position in Aspen Aerogels in Q2 2024 and has held it in 8 quarters since.
  • IMC Chicago's Aspen Aerogels position peaked at $1.45M in Q4 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.